The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Commensal bacteria make GPCR ligands that mimic human signalling molecules
Open accessAbstract
Commensal bacteria are believed to have important roles in human health. The mechanisms by which they affect mammalian physiology remain poorly understood, but bacterial metabolites are likely to be key components of host interactions. Here we use bioinformatics and synthetic biology to mine the human microbiota for N-acyl amides that interact with G-protein-coupled receptors (GPCRs). We found that N-acyl amide synthase genes are enriched in gastrointestinal bacteria and the lipids that they encode interact with GPCRs that regulate gastrointestinal tract physiology. Mouse and cell-based models demonstrate that commensal GPR119 agonists regulate metabolic hormones and glucose homeostasis as efficiently as human ligands, although future studies are needed to define their potential physiological role in humans. Our results suggest that chemical mimicry of eukaryotic signalling molecules may be common among commensal bacteria and that manipulation of microbiota genes encoding metabolites that elicit host cellular responses represents a possible small-molecule therapeutic modality (microbiome-biosynthetic gene therapy).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, a recent paper described that commensal bacteria are able to produce G-protein-coupled receptor agonists to regulate the GI tract physiology, including metabolic hormones and glucose homeostasis [4].”
From Anxiety, depression, and the microbiome: A role for gut peptides (2018) · cites this paper as [4]
In the citing paper
“Although microbes secrete eCBs, their role in host physiology remains unclear (255).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [255]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Fu, J., Gaetani, S., Oveisi, F., Verme, J., Serrano, A., de Fonseca, F. D., Rosengarth, A., Luecke, H., Giacomo, B. D., Tarzia, G., et al. (2003) · Nature · doi:10.1038/nature01921 · Cited by 1,113
Relating the metatranscriptome and metagenome of the human gut
Franzosa, E. A., Morgan, X. C., Segata, N., Waldron, L., Reyes, J. A., Earl, A. M., Giannoukos, G., Boylan, M. R., Ciulla, D., Gevers, D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319284111 · Cited by 731
Overton, H. A., Babbs, A. J., Doel, S. M., Fyfe, M. C. T., Gardner, L. S., Griffin, G., Jackson, H. C., Procter, M. J., Rasamison, C. M., Tang‐Christensen, M., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.004 · Cited by 670
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut
Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi‐Nishida, E., Tsuboi, K., Sugimoto, Y., Kobayashi, T., Miyachi, Y., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14459 · Cited by 443
Modulating the endocannabinoid system in human health and disease – successes and failures
Pacher, P., & Kunos, G. (2013) · FEBS Journal · doi:10.1111/febs.12260 · Cited by 418
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut
Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi‐Nishida, E., Tsuboi, K., Sugimoto, Y., Kobayashi, T., Miyachi, Y., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214459 · Cited by 418
Lauffer, L. M., Iakoubov, R., & Brubaker, P. L. (2009) · Diabetes · doi:10.2337/db08-1237 · Cited by 405
Chu, Z., Carroll, C., Alfonso, J., Gutierrez, V., He, H., Lucman, A., Pedraza, M., Mondala, H., Gao, H., Bagnol, D., et al. (2008) · Endocrinology · doi:10.1210/en.2007-0966 · Cited by 387
Mimee, M., Tucker, A. C., Voigt, C. A., & Lu, T. K. (2015) · Cell Systems · doi:10.1016/j.cels.2015.06.001 · Cited by 387
Endocannabinoids–at the crossroads between the gut microbiota and host metabolism
Cani, P. D., Plovier, H., Van Hul, M., Geurts, L., Delzenne, N. M., Druart, C., & Everard, A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.211 · Cited by 367
2-Oleoyl Glycerol Is a GPR119 Agonist and Signals GLP-1 Release in Humans
Hansen, K. B., ROSENKILDE, M. M., Knop, F. K., Wellner, N., Diep, T. A., Rehfeld, J. F., Andersen, U. B., Holst, J. J., & Hansen, H. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0647 · Cited by 298
Chu, Z., Jones, R. M., He, H., Carroll, C., Gutierrez, V., Lucman, A., Moloney, M. K., Gao, H., Mondala, H., Bagnol, D., et al. (2007) · Endocrinology · doi:10.1210/en.2006-1608 · Cited by 295
Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity
Chen, Z., Guo, L., Zhang, Y., L. Walzem, R., Pendergast, J. S., Printz, R. L., Morris, L. C., Matafonova, E., Stien, X., Kang, L., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72517 · Cited by 277
Production of α-Galactosylceramide by a Prominent Member of the Human Gut Microbiota
Brown, L. C. W., Peñaranda, C., Kashyap, P., Williams, B. B., Clardy, J., Kronenberg, M., Sonnenburg, J. L., Comstock, L. E., Bluestone, J. A., & Fischbach, M. A. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001610 · Cited by 262
Mice Lacking the Orphan G Protein-Coupled Receptor G2A Develop a Late-Onset Autoimmune Syndrome
Le, L. Q., Kabarowski, J. H. S., Weng, Z., Satterthwaite, A. B., Harvill, E. T., Jensen, E. R., Miller, J. F., & Witte, O. N. (2001) · Immunity · doi:10.1016/s1074-7613(01)00145-5 · Cited by 215
Cohen, L. J., Kang, H., Chu, J., Huang, Y.-H., Gordon, E. A., Reddy, B. V. B., Ternei, M. A., Craig, J. W., & Brady, S. F. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508737112 · Cited by 208
Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology
Chen, Y., Ji, F., Guo, J., Shi, D., Fang, D., & Li, L. (2016) · Scientific Reports · doi:10.1038/srep34055 · Cited by 205
Amino acid-containing membrane lipids in bacteria
Geiger, O., González‐Silva, N., López-Lara, I. M., & Sohlenkamp, C. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.08.002 · Cited by 194
Ou, G., Hedberg, M., Hörstedt, P., Baranov, V., Forsberg, G., Drobni, M., Sandström, O., Nyunt Wai, S., Johansson, I., Hammarström, M.-L., et al. (2009) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.524 · Cited by 169
Hong, L., Vassileva, G., Corona, A., Liu, L., Baker, H. E., Golovko, A., Abbondanzo, S. J., Hu, W., Yang, S., Ning, Y., et al. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0453 · Cited by 167
E-type prostanoid receptor 4 (EP4) in disease and therapy
Kónya, V., Marsche, G., Schuligoi, R., & Heinemann, Á. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.03.006 · Cited by 158
Duodenal microbiota composition and mucosal homeostasis in pediatric celiac disease
Cheng, J., Kalliomäki, M., Heilig, H. G., Palva, A., Lähteenoja, H., de Vos, W. M., Salojärvi, J., & Satokari, R. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-113 · Cited by 152
G2A and LPC: Regulatory functions in immunity
Kabarowski, J. H. S. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.04.007 · Cited by 144
Exploring and Understanding the Biochemical Diversity of the Human Microbiota
Koppel, N., & Balskus, E. P. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2015.12.008 · Cited by 140
Schulze, T., Golfier, S., Tabeling, C., Räbel, K., Gräler, M. H., Witzenrath, M., & Lipp, M. (2011) · The FASEB Journal · doi:10.1096/fj.10-179028 · Cited by 118
Ritter, K., Buning, C., Halland, N., Pöverlein, C., & Schwink, L. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01198 · Cited by 118
Katz, L., Gambale, J. J., Rothenberg, P., Vanapalli, S. R., Vaccaro, N. M., Xi, L., Sarich, T. C., & Stein, P. P. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01587.x · Cited by 110
Functional expression of dental plaque microbiota
Peterson, S. N., Meißner, T., Su, A. I., Snesrud, E. C., Ong, A., Schork, N. J., & Bretz, W. A. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00108 · Cited by 106
Rimmerman, N., Bradshaw, H. B., Hughes, V., Chen, J. S.-C., Hu, S. S., McHugh, D., Vefring, E., Jahnsen, J. A., Thompson, E. L., Masuda, K. R., et al. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045997 · Cited by 96
Flock, G. B., Holland, D. P., Seino, Y., & Drucker, D. J. (2010) · Endocrinology · doi:10.1210/en.2010-1047 · Cited by 84
Mucosally transplanted mesenchymal stem cells stimulate intestinal healing by promoting angiogenesis
Manieri, N. A., Mack, M. R., Himmelrich, M. D., Worthley, D. L., Hanson, E. M., Eckmann, L., Wang, T. C., & Stappenbeck, T. S. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81423 · Cited by 79
Nunez, D. J., Bush, M., Collins, D. A., McMullen, S. L., Gillmor, D., Apseloff, G., Atiee, G. J., Corsino, L., Morrow, L., & Feldman, P. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092494 · Cited by 65
MOLECULAR EVOLUTION OF GPCRS: CRH/CRH receptors
Lovejoy, D. A., Chang, B. S. W., Lovejoy, N. R., & del Castillo, J. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0238 · Cited by 63
Chemical ecology in retrospect and prospect
Meinwald, J., & Eisner, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800649105 · Cited by 61
Zhang, X., Ferguson-Miller, S. M., & Reid, G. E. (2008) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2008.08.017 · Cited by 59
GPR119: “Double-Dipping” for Better Glycemic Control
Lauffer, L., Iakoubov, R., & Brubaker, P. L. (2008) · Endocrinology · doi:10.1210/en.2008-0182 · Cited by 55
Oleoylethanolamide: Effects on hypothalamic transmitters and gut peptides regulating food intake
Serrano, A., Pavón, F. J., Tovar, S. A., Casanueva, F. F., Señarís, R. M., Diéguez, C., & de Fonseca, F. R. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.12.007 · Cited by 46
Khan, S. Y., McLaughlin, N., Kelher, M. R., Eckels, P. C., Gamboni-Robertson, F., Banerjee, A. M., & Silliman, C. C. (2010) · Biochemical Journal · doi:10.1042/bj20091087 · Cited by 41
Wagoner, R. M. V., & Clardy, J. (2006) · Structure · doi:10.1016/j.str.2006.07.005 · Cited by 40
Genomic insights into mediator lipidomics
Hla, T. (2005) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2005.06.008 · Cited by 34
Moore, E. K., Hopmans, E. C., Rijpstra, W. I. C., Sánchez‐Andrea, I., Villanueva, L., Wienk, H., Schoutsen, F., Stams, A. J. M., & Damsté, J. S. S. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00637 · Cited by 29
Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus
Ha, T.-Y., Kim, Y. S., Kim, C. H., Choi, H., Yang, J. W., Park, S. H., Kim, D. H., & Rhee, J.-K. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0209-0 · Cited by 21
MOLECULAR EVOLUTION OF GPCRS: What we know and what the future holds
Vaudry, H. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0103 · Cited by 8
Tang, Y., Li, X., Han, X., Lu, J., & Diwu, Z. J. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.04.051 · Cited by 2
Cited by
Sorted by citations
Gut microbiota in human metabolic health and disease
Fan, Y., & Pedersen, O. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0433-9 · Cited by 4,724
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
Trends in GPCR drug discovery: new agents, targets and indications
Hauser, A. S., Attwood, M. M., Rask‐Andersen, M., Schiöth, H. B., & Gloriam, D. E. I. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.178 · Cited by 2,714
Gut microbiome and health: mechanistic insights
de Vos, W. M., Tilg, H., Van Hul, M., & Cani, P. D. (2022) · Gut · doi:10.1136/gutjnl-2021-326789 · Cited by 2,388
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Drucker, D. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.001 · Cited by 2,170
Metadata
- Authors
- Cohen, L. J., Esterhazy, D., Kim, S.-H., Lemetre, C., Aguilar, R. R., Gordon, E. A., Pickard, A. J., Cross, J. R., Emiliano, A. B., Han, S. M., Chu, J., Vila-Farres, X., Kaplitt, J., Rogoz, A., Calle, P. Y., Hunter, C., Bitok, J. K., & Brady, S. F.
- Affiliations
- Rockefeller University (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Brady, Sean F.
- ORCID
- Venue
- Nature
- Published
- 2017-08-30
- Volume
- 549
- Issue
- 7670
- Pages
- 48-53
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5777231
- OpenAlex
- W2753100975
- Cited by
- 500
- References
- 45
- Citations by year
- 2026: 44 · 2025: 47 · 2024: 60 · 2023: 53 · 2022: 52 · 2021: 44 · 2020: 64 · 2019: 62 · 2018: 55 · 2017: 18
- FWCI
- 22.22
- Type
- journal article
- Language
- en
- Update notices
- erratum (2018-04-05)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Crohn's and Colitis Foundation (370629)
- National Institute of General Medical Sciences (U01GM110714, R35GM122559)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007792, K08DK109287)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- commensal bacteria, G protein-coupled receptors, GPR119, gut microbiota metabolites, glucose homeostasis, metabolic hormones, gastrointestinal tract physiology
- MeSH terms
- Biological Mimicry, Gastrointestinal Microbiome, Amides, Animals, Bacteria, Blood Glucose, Female, Homeostasis, Humans, Ligands, Male, Symbiosis, Signal Transduction, Gastrointestinal Tract, Receptors, G-Protein-Coupled, Mice, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review